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Objective: Evaluate the effects of simvastatin in the process of fracture healing in rat tibia. 
Methods: Thirty-six rats were subjected to diaphyseal fracture of the leg bones and divided 
in the statin group (GE) and control group (GC), being subdivided into three subgroups 
according to days post-fracture (7th, 14th and 28th day) to assess bone healing. In GE was 
administered by gavage a solution of simvastatin to the sacrifice. In the control group 
was administered saline by the same route of SG. Immobilization was not used. After the 
sacrifice was made to limb amputation in the distal femur and conducted the clinical, 
radiological and histological analysis. Clinical evaluation was made as to the mobility 
of the fracture. Then the samples were radiographed and evaluated for callus diameter. 
Histological examination was performed with cuts of 5 micrometers and stained with 
hematoxylin-eosin, Masson’s trichrome and Alcian blue pH 2.5. The level of significance to 
exclude the null hypothesis was 5%. Results: All GE animals showed greater stability of the 
fracture and higher callus area. There were no significant changes in the histological study. 
Conclusion: Simvastatin accelerates the consolidation process by increasing the callus, but 
does not alter the histology of the newly formed bone.
© 2013 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora 
Ltda. 
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Introduction
Many studies have indicated that statins act towards 
remodeling and formation of bone tissue and are thus 
osteoinductive substances. 
Mundy et al.1 reported from studies on rodents that statins 
have anabolic effects on bone, with stimulation of bone 
tissue formation. Statins are believed to act by strengthening 
the expression of bone morphogenic protein-2 (BMP-2) 
in osteoblasts. However, in attempting to reproduce the 
experiments of Mundy et al.,1 Maritz et al.2 did not find the 
expected effect from statins. On the contrary, they reported 
that simvastatin produced an inhibitory effect with regard to 
bone formation, with increased bone reabsorption.
Several clinical investigations have reexamined the study 
series by means of observational and cohort experiments, in an 
attempt to evaluate the effect of statins on bone metabolism, 
fracture risk and bone consolidation.
Staal et al.3 reported that statins act by inhibiting the 
mevalonate pathway. Mevalonate is the precursor for formation 
of steroids and the isoprenoids of steroids. These are involved 
in cell membrane biogenesis, DNA reproduction and protein 
glycosylation in a variety of cells. Statins inhibit the activity of 
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA), 
thereby reducing cholesterol synthesis, which is required for 
conversion of HMG-CoA to mevalonate, and this is the same 
pathway as in bisphosphonate action. In acting to diminish 
mevalonate synthesis, statins interfere with cell proliferation 
and activity. 
Baek et al.4 studied the effect of simvastatin on the 
proliferation and differentiation of cells of the bone marrow 
stroma in culture medium. They isolated mononuclear cells 
and cultured an osteoblastic lineage from the bone marrow of 
healthy volunteers. In the first culture medium, simvastatin 
diminished the average size of the colonies that give shape 
to fibroblastic units (colony-forming units, CFU-Fs) and 
emphasized calcification of the matrix. These cells were 
subcultured and the alkaline phosphatase activity of each 
group was measured in relation to time. Simvastatin increased 
the alkaline phosphates activity in a dose-dependent manner, 
and the effect was most evident over the initial periods of 
culturing. It was concluded from that study that simvastatin 
has a stimulatory effect on bone formation by means of 
osteoblastic differentiation.
Researchers from the Heart Protection study did not 
reported any difference in hospital treatment for the same type 
of fractures caused by car accidents, between the group that 
used simvastatin (40 mg/day) and the placebo group.5
Through these studies, contradictory results regarding the 
effect of statins on bone metabolism have been generated.6 
Moreover, the action of this drug on fractures, mineral density 
and bone remodeling in humans is uncertain. Thus, a path 
towards new studies has been opened up, through the need for 
further observational, clinical, randomized and experimental 
studies on statin use at appropriate doses. 
The aim of this paper was to evaluate the effect of statins 
on fracture healing in rats.
Methodology
Thirty-six adult male Wistar rats (Rattus norvegicus albinus; 
Rodentia: Mammalia), aged 45 to 65 days and weighing 200 
to 300 g, were used. They were housed in the Laboratory of 
the Maranhão Academic League of Experimental Surgery 
(LabLacema), in polypropylene boxes (0.15 m2), with a 
maximum of five animals in each box. This study followed 
the standards of the Nomina Anatomica Veterinaria7 and the 
ethical principles for animal experimentation (Cobea), and it 
had been approved by the Ethics Committee of the Veterinary 
Department of Universidade Estadual do Maranhão.
Each animal was anesthetized with ketamine at a dose of 
75 mg/kg and xylazine at a dose of 8 mg/kg intramuscularly 
in the left gluteal region. Antisepsis was performed on the 
right hind leg using a degerming solution and iodine-based 
antisepsis.
To produce the tibial fracture, pliers with three pressure 
points were used, in accordance with the technique established 
by Otto et al.8 The rats then remained housed in their respective 
boxes, without any type of immobilization or restriction of 
weight-bearing on the fractured limb. 
The animals were distributed randomly by means of a draw 
into two groups of 18, which were named the statin group (SG) 
and control group (CG). Each group was divided into three 
subgroups (SSG and SCG) that were defined with numerical 
suffixes corresponding to the number of days between the 
surgical procedure and sacrifice, thus:
SSG-07 and SCG-07: (sacrifice on the 7th day) – five rats in 
each subgroup;
SSG-14 and SCG-14: (sacrifice on the 14th day) – five rats in 
each subgroup;
SSG-28 and SCG-28: (sacrifice on the 28th day) – eight rats 
in each subgroup.
These intervals between fracture production and sacrifice 
of the animals followed the experimental model proposed by 
Padula et al.9
Each rat was weighed and identified in its box with stripes 
made using a CD pen on the animal’s tail. The rat identified 
as R1 was marked with one transverse stripe, R2 with two 
transverse stripes, R3 with three transverse stripes, R4 with 
one longitudinal stripe and R5 was not marked but was only 
subjected to the stress using a pen without ink. For SSG-28 and 
SCG-28, there were four animals in four boxes (two in each 
subgroup), thus making a total of 16 animals, which were 
identified as R1 to R4.
The SG rats were subjected to oral gavage with a simvastatin 
solution at a dose of 20 mg/kg, 12 hours after fracture 
production, and this was repeated every 24 hours. In the CG, 
gavage was performed using placebo. Gavage was performed 
every day until the date of sacrifice.
The animals were sacrificed after being weighed, and this 
was done by administering a lethal intraperitoneal dose of 
barbiturate after induction of anesthesia using halothane, 
and the act was completed with a lethal dose of potassium 
chloride. The hind leg was amputated at the level of the middle 
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Grade 4 Complete bone union
Grade 3 Bone union incomplete due to presence of small 
quantity of cartilage in the callus
Grade 2 Well-formed hyaline cartilage bridge can be seen, 
uniting the main fragments (complete cartilaginous 
union
Grade 1 Incomplete cartilaginous union, with retention of 
fibrous elements in the chondral plate
Grade 0 Absent or delayed fracture repair, characterized by 
presence of cartilage between the fragments and 
remains of hematoma or other fluid (pseudarthrosis)
Chart 1 - Histomorphological classification proposed by 
Allen et al. for staging bone consolidation.
third of the femur in order to study the bone callus. The skin 
around the musculature of the tibia was then removed without 
damaging the muscle group.
The mobility of the fracture focus was clinically evaluated. 
Grade 0 was attributed to consolidated fractures, grade 1 to 
intermediate patterns of movement and grade 2 to cases of 
clear movement.10 All the examiners were defined by means 
of a draw and they were unaware of which group they were 
going to examine. After the clinical evaluation of mobility of the 
fracture focus, the surgical specimen was fixed in 10% formol. 
The area of the bone callus was assessed by means of 
analysis on digital radiographs, using the Auto CAD® 2007 
software (Fig. 1). The entire callus area was delimited and 
measured in mm2.
For the histological analysis, the fractured tibiae and their 
surrounding soft tissues were decalcified for 12 to 15 hours 
and then dehydrated, clarified and embedded in paraffin. 
Sections of thickness 5 micrometers were cit sagittally to the 
fracture plane, using a microtome. These sections were stained 
with hematoxylin-eosin (HE), Masson’s trichrome (MT) and 
Alcian blue pH 2.5 (AB). HE and MT were used to study the 
cellularity of the extracellular matrix, while AB showed the 
sulfated and non-sulfated acid proteoglycans, which reflect 
the chondrogenic activity. All the laminas were analyzed by 
means of optical microscopy. The stage of bone consolidation 
was determined in accordance with the classification system 
proposed by Allen et al.11 (Chart 1).
Fig. 1 - Use of Autocad® for calculating the area of the 
callus.
Descriptive statistical techniques were applied, thus 
enabling exploratory analysis through parameter estimates 
(mean standard deviation and median) for all the variables 
investigated in this study. Following this, bone consolidation 
was assessed by means of the dependent variable (bone area) 
in relation to the independent variables of days and groups.
Considering that the sample size was small and that the 
data did not present normal distribution, the nonparametric 
Mann-Whitney test was performed. To analyze the histological 
data, quantitative assessment was performed using Fisher’s 
exact test. For all the tests, the significance level for rejecting 
the nullity hypothesis was 5%.
Results
All the animals accepted the diet well and could move around 
after receiving the fracture. They presented claudication of the 
fractured limb after an average of six to eight days, and there 
was no difference between the statin group (SG) and the control 
group (CG). None of the animals presented an operative wound 
at the fracture site. 
Clinical analysis
Regarding the mobility of the fracture focus after seven days, 
in SCG-07 there were four animals with intermediate mobility 
(grade 1) and one with clear mobility (grade 2), while in SSG-07 
all five animals had intermediate mobility (grade 1).
In the subgroup evaluated 14 days after fracturing, there 
were four animals in SCG-14 without mobility (grade 0) and one 
with intermediate mobility (grade 1), while all five animals in 
SSG-14 had mobility grade 0.
All the animals that were evaluated 28 days after receiving 
the fracture presented mobility grade 0 on examination.
Fig. 2 - Radiographs on the SSG and SCG subgroups on the 28th 
day.
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Radiological analysis
All the animals in the subgroups that were sacrificed on 
the seventh day presented fractures of the tibia and fibula, 
thus demonstrating that the fracture closure took place in a 
standardized manner. No radiological bone callus was found 
in any of the rates at this time.
Among the subgroups that were sacrificed on the 14th and 
28th days, bone calluses and bone bridges were seen in all the 
rats. In SSG-14, the mean area of the callus was 66.65 mm², 
while in SCG it was 55.29 mm². SSG-28 also had a greater mean 
area of bone callus than SCG-28, with values of respectively 
67.46 mm2 and 56.09 mm2 (Fig. 2). Therefore, the simvastatin 
group presented a mean bone callus size that was greater than 
in the control group, both in the 14 and 28-day evaluations and 
in the overall assessment.
There was a significant difference in relation to callus area 
(p = 0.043), such that the average area in the statin group (67.1 
mm2) was greater than the area in the control group (55.4 mm2).
four grade 3, two grade 2 and one grade 1. In SSG-28, there was 
bone callus grade 3 in six animals (Fig. 5) and grade 1 in two. 
In all the animals of this subgroup, bone tissue with presence 
of osteocytes and osteoblasts was found. 
In the quantitative evaluation, Fisher’s exact test was used 
and no statistically significant difference was found between 
the groups.
Discussion
The bone consolidation process is influenced by a variety 
of factors that have been studies in depth from the times of 
Hippocrates to the present day. 
In the present study, simvastatin was chosen from among 
various inhibitors of HMG-CoA reductase because like 
atorvastatin and cerivastatin, it presents greater in vitro 
effects on bone than seen with lovastatin and pravastatin.3
Oxlund and Andreassen12 found that treatment with 
simvastatin at a dose of 20 mg/kg orally partially impeded 
bone loss in female Wistar rats that were subjected to 
ovariectomy, and also increased cortical bone formation. 
Based on these authors’ results, we used this dose taking 
into account simvastatin metabolism in the liver, in order 
to investigate its effect on bone tissue.
Some authors, like Skoglund et al.,13 used much larger 
doses of the drug, of 120 mg/kg, in order to demonstrate the 
effects of statins on bone consolidation in animals. They 
concluded that animals only presented increased bone callus 
area and noted that simvastatin acts on the mechanism for 
mobilization of cells involved in the fracture repair process, 
thereby leading to increased bone callus size.
Fig. 3 - Photomicrographs of sections from animals in the 
14-day subgroups, grade 1, SSG-14. (a) Presence of many 
neoformed vessels in fibrous connective tissue, with 
presence of formation of immature bone tissue. H&E x4.  
(b) With MT.
Histological analysis
All the rats were histologically evaluated by the pathologist 
responsible, in a random manner without access to or 
knowledge of the control group, the group divisions or the 
respective days of sacrifice of each subgroup.
In SCG-07, there were elements of fibrous connective tissue, 
absence of or only small focal areas of bone tissue, with bone 
calluses of grade 1 observed in three animals and grade 0 
in two. In SSG-07, there was fibrous connective tissue and 
cartilaginous tissue, with the periphery of the callus composed 
of elements of mature and immature bone tissue. In four 
animals, grade 1 bone callus was seen and in one, grade 0.
In SCG-14, four rats presented fibrous connective tissue and 
all of them had elements of chondrogenesis. There was grade 1 
bone callus in four of these animals and grade 2 in only one. In 
SSG-14, three rats were classified as grade 2 and two as grade 
1, and bone tissue was present on the periphery of the callus 
(Figs. 3 and 4).
In SCG-28, there was greater variation regarding the Allen 
classification. In this subgroup, one had bone callus of grade 4, 
Fig. 4 - Photomicrographs of sections from animals in the 
14-day subgroups, grade 2. (A) SCG-14. Bone extremity with 
mature cartilaginous tissue, with complete union. HE x4. 
(B) SSG-14. Extremity with mature cartilaginous, forming 
complete hyaline bridge. HE x4. (C) SSG-14. Opposite 
extremity with vascular neoformation. MT x4.
Fig. 5 - Photomicrographs of sections from animals in SSG-
28, grade 3. Formation of incomplete bone tissue due to 
presence of cartilaginous tissue in focal area  
(a – magnifying glass) and (b – x4).
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In our study, we also observed that the bone callus area 
increased, thus corroborating these authors’ affirmation.13 
The acceleration of the consolidation process in the statin 
group may have occurred in SSG-07, but this could not be 
seen in our study because the callus is radiotransparent at 
this stage of radiographic evaluation. On the other hand, both 
SSG-14 and SSG-28 presented large areas of bone callus, thus 
demonstrating acceleration of the consolidation process.
However, in the study by Skoglund et al.,13 the results 
relating to the callus in the rats treated with simvastatin 
for 14 days were better than ours, with a cross-sectional 
area 53% larger than that of the control. However, after 21 
days of treatment, the fracture consolidation did not present 
any differences between the control group and simvastatin 
group. In our study, SSG-28 presented bone callus size greater 
than that of the control, thus disagreeing with the above 
authors.
The findings of Maritz et al.,2 in which statins increased 
the bone metabolism rate, thus increasing both bone 
formation and bone reabsorption, seem to favor bone 
consolidation when statins are used.
We also agree with the findings of Tsubone et al.,14 
regarding the capacity of statins to promote bone formation 
and improve the consolidation process. These authors 
studied cerivastatin used in bone transplantations in 
rat tibiae and found through histological analyses that it 
increased the formation of new bone tissue and increase 
bone union.
As already described, the mechanism for inducing bone 
consolidation triggered by simvastatin is mediated by 
increased production of BMP-2. Therefore, it is possible to 
compare the results from studies that used BMP-2 rh in the 
consolidation process and those that used statins.15 
Stein et al.15 studied the effects of rhBMP-2 on consolidation 
of unstable and stable fractures of the tibia in rabbits, 
administered in biodegradable particles, in collagen gel 
or by injection. When rhBMP-2 was injected, the callus of 
mechanically unstable fractures developed more rapidly. In the 
same way as in our study on statins, these authors concluded 
that although BMP-2 accelerates the callus development 
rate and cortical bone union, it does not affect the quantity 
of bone and cartilage produced. In our study, there was no 
statistically significant difference regarding histomorphological 
classification when 7, 14 and 28 were compared. However, 
there were certain variations in histological grade between 
the different subgroups.
Conclusion
Simvastatin promoted greater clinical stability for the fracture 
focus and increased the size of the bone callus, 14 and 28 
days after the fracturing event, such that this difference was 
statistically significant. It also produced a difference in the 
histological analysis on the callus, but without statistical 
significance. 
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